Tokyo - Delayed Quote JPY

SEED Co.,Ltd. (7743.T)

785.00 0.00 (0.00%)

At close: November 2 at 3:30:00 PM GMT+9

Chart Range Bar

Loading chart for 7743.T

Previous Close 785.00
Open 785.00
Bid 785.00 x --
Ask 787.00 x --
Day's Range 785.00 - 786.00
52 Week Range 468.00 - 794.00
Volume 70,100
Avg. Volume 257,175
Market Cap (intraday) 23.759B
Beta (5Y Monthly) -0.07
PE Ratio (TTM) 21.79
EPS (TTM) 36.02
Earnings Date (est.) --
Forward Dividend & Yield 15.00 (1.91%)
Ex-Dividend Date Mar 30, 2026
1y Target Est --

SEED Co.,Ltd. manufactures and sells contact lenses and care products in Japan. The company offers daily disposable contact lenses; bi-weekly/monthly contact lenses or monthly replacement; astigmatic and bifocal contact lenses; astigmatic and bifocal contact lenses; rigid gas permeable contact lenses; and medical contact lenses, including orthokeratology and iris lens. It also provides multipurpose solution (MPS) for soft contact lenses; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products. SEED Co.,Ltd. was incorporated in 1957 and is headquartered in Tokyo, Japan.

www.seed.co.jp

1,048

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Medical Instruments & Supplies

Industry

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

7743.T

39.88%

Nikkei 225 (^N225)

25.31%

1-Year Return

7743.T

41.60%

Nikkei 225 (^N225)

20.36%

3-Year Return

7743.T

10.84%

Nikkei 225 (^N225)

97.44%

5-Year Return

7743.T

41.45%

Nikkei 225 (^N225)

113.69%

Earnings Per Share (GAAP)

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q1 FY27

Revenue 8.85B

Earnings 336M

Profit Margin 3.80%

FY26

FY27

1.0%

2.0%

3.0%

4.0%

5.0%

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

3.18%
Return on Assets (ttm)

1.51%
Return on Equity (ttm)

5.78%
Revenue (ttm)

34.24B
Net Income Avi to Common (ttm)

1.09B
Diluted EPS (ttm)

36.02

Balance Sheet and Cash Flow

Total Cash (mrq)

5.85B
Total Debt/Equity (mrq)

207.35%
Levered Free Cash Flow (ttm)

-8.75B

8242.T H2O Retailing Corporation

2,871.50 +3.22%

8281.T Xebio Holdings Co., Ltd.

1,077.00 0.00%

6470.T Taiho Kogyo Co., Ltd.

1,045.00 -2.25%

6482.T Yushin Company

636.00 -1.40%

6306.T Nikko Co., Ltd.

944.00 +0.11%

U.S. markets close in 5h 44m

SEED Co.,Ltd. (7743.T)

-0.13%

-1.01%

46.18%

36.52%

38.20%

25.40%

306.03%

SEED Co.,Ltd. Overview Medical Instruments & Supplies / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share (GAAP)

Revenue vs. Earnings

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch